| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00007890-199905150-00007 |
| P8608 | Fatcat ID | release_fsguihjzxjfaffdktrzfrflcya |
| P698 | PubMed publication ID | 10342315 |
| P5875 | ResearchGate publication ID | 232218600 |
| P50 | author | Julie Sheldon | Q37374600 |
| P2093 | author name string | Antoine C | |
| Bedrossian J | |||
| Hiesse C | |||
| Lang P | |||
| Legendre C | |||
| Loirat C | |||
| Tuppin P | |||
| Marjanovic Z | |||
| Peraldi MN | |||
| Schulz TF | |||
| Gagnadoux MF | |||
| Farge D | |||
| Agbalika F | |||
| Lebbé C | |||
| Mouquet C | |||
| Golmard JL | |||
| Pellet C | |||
| P2860 | cites work | KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma | Q28284765 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Kaposi's sarcoma | Q725345 |
| P304 | page(s) | 1236-1242 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF). | |
| P478 | volume | 67 |
| Q34627227 | Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells |
| Q40938163 | Comparative evaluation of three serological methods for detection of human herpesvirus 8-specific antibodies in Canadian allogeneic stem cell transplant recipients |
| Q35574167 | Confirming high prevalence of human herpesvirus 8 infection in chronic kidney disease patients in São Paulo, Brazil |
| Q52290156 | De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation. |
| Q36905397 | Erythropoietic therapy: cost efficiency and reimbursement |
| Q34305137 | Gastrointestinal infections in the immunocompromised host |
| Q45627901 | Human herpes virus-8 serology and DNA analysis in recipients of renal allografts showing Kaposi's sarcoma and their respective donors |
| Q42272326 | Human herpesvirus 6, 7 and 8 in solid organ transplantation |
| Q34722916 | Human herpesvirus type 8 infections among solid organ transplant recipients |
| Q40259107 | Human herpesviruses 6, 7 and 8 in solid organ transplant recipients |
| Q26748580 | Incidence, risk factors and outcomes of de novo malignancies post liver transplantation |
| Q34379808 | Infections in recipients of kidney transplants |
| Q34774797 | KSHV LANA--the master regulator of KSHV latency |
| Q73741307 | KSHV reactivation in post-transplant Kaposi sarcoma |
| Q34594736 | Kaposi sarcoma in transplantation |
| Q34105636 | Kaposi sarcoma involving the gastrointestinal tract |
| Q90319829 | Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Associated Disease in the AIDS Patient: An Update |
| Q38885022 | Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays |
| Q36154559 | Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects |
| Q35044342 | Laboratory diagnosis of human herpesvirus 8 infection in humans |
| Q36223625 | Linking KSHV to human cancer |
| Q38208275 | Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases |
| Q38107277 | Oral Kaposi's sarcoma: a review and update |
| Q47547020 | Post-transplant malignancies in pediatric liver transplant recipients: Experience of two centers in Turkey. |
| Q44319179 | Posttransplantation Kaposi sarcoma-experience in a patient receiving FK-506 and MMF. |
| Q34228263 | Potent antiviral activity of north-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus |
| Q24673299 | Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling |
| Q34295807 | Reactivation and role of HHV-8 in Kaposi's sarcoma initiation |
| Q40055993 | Seroprevalence of Human Herpesvirus 8 and its Impact on the Hemoglobin Level in Patients of End Stage of Renal Diseases. |
| Q33906970 | Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases |
| Q37560792 | Structure of the Open Reading Frame 49 Protein Encoded by Kaposi's Sarcoma-Associated Herpesvirus |
| Q78407378 | Successful treatment of post-renal transplant Kaposi's sarcoma with paclitaxel |
| Q58481173 | Transplanting cancer: donor-cell transmission of Kaposi sarcoma |
| Q34198401 | Viral infections after renal transplantation |
| Q81395065 | [Effects of viral infection on transplant recipients] |
| Q81573523 | [Kaposi's sarcoma and organ transplantation: 22 cases] |
Search more.